Norway· NO-ID_601259DF-2DCA-438E-90D8-22BEC2B5A200

Emadine

A emedastine product containing emedastine, registered in Norway by Immedica Pharma AB (1). The same ATC class is registered in 12 of our 19 countries.

ATC S01GX06

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedEmadineATCS01GX06REGISTER NO.NO-ID_601259DF-2DCA-4…PACKS LISTED5CHECKEDSeptember 25, 2026

Where it is registered

Emedastine is registered in 12 of 19 countries.

Countries holding a registration under ATC S01GX06 (emedastine), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 7 of them publish a price we can compare per daily dose

Emedastine · ATC S01GX06

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Emedastine
Manufacturer
Immedica Pharma AB (1)
Country
Norway (NO)
ATC code
S01GX06
ATC class
Emedastine
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 5

2 priced
  • gtin
    7350110580378
  • no_merkevare_id
    ID_601259DF-2DCA-438E-90D8-22BEC2B5A200
  • no_varenummer
    008903
    30 x 0.35
    NOK 223.9
  • no_varenummer
    527523
    5
    NOK 145
  • gtin
    7350110580316

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Emedastine in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All emedastine products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Iceland · Emadine
  • Liechtenstein · Emadine

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1568d53e-6945-4bc3-913a-19a4008b9e66
GET /v1/drugs/1568d53e-6945-4bc3-913a-19a4008b9e66?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Øyedråper, oppløsning",
  "source": "fest",
  "status": "A",
  "atc_name": "Emedastin",
  "merkevare_id": "ID_601259DF-2DCA-438E-90D8-22BEC2B5A200",
  "name_form_strength": "Emadine øyedr, oppl 0,05 % w/v",
  "prescription_group": "C"
}

See everything about emedastine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.